Literature DB >> 12553469

Clostridial myonecrosis in horses (37 cases 1985-2000).

S F Peek1, S D Semrad, G A Perkins.   

Abstract

REASONS FOR PERFORMING STUDY: Previous reports of clostridial myonecrosis have either focused on individual case reports or have been small retrospective studies reporting very high mortality rates.
OBJECTIVES: The objective of this study was to describe the outcome of cases of clostridial myonecrosis submitted to 2 referral equine hospitals in the United States over a 15 year period.
METHODS: A retrospective study of case material selected on the basis of positive Clostridium spp. culture or the identification of Clostridium spp. by specific fluorescent antibody testing from soft tissue wounds was performed at Cornell and Wisconsin.
RESULTS: 37 cases of clostridial myonecrosis were documented. Twenty-seven horses survived, 8 were subjected to euthanasia and 2 died during treatment for an overall survival rate of 73%. Twenty-five cases (68%) were associated with Clostridium perfringens alone, 6 cases (16%) with Cl. septicum alone, 4 cases with mixed clostridial infections (11%), 1 case with Cl. sporogenes and 1 with an unspeciated Clostridium spp. The highest survival rate of 81% was documented for those cases from which Cl. perfringens alone was isolated. The most common antecedent condition prior to referral was colic. The myonecrotic lesion occurred within 6-72 h of a soft tissue injection in 34 cases but was associated with a wound or laceration in the remaining 3 cases. Of the 34 cases associated with recent injections, 24 were associated with i.m. injections in the cervical region, 4 in the semimembranosus/semitendinosus region, 3 in the gluteal region, 2 with perivascular leakage of drugs administered into the jugular vein and 1 case developed simultaneously in the gluteal and neck region following injections at both sites.
CONCLUSIONS: Clostridial myonecrosis can occur following the i.m. or inadvertent perivascular administration of a wide variety of commonly administered drugs. It is most common in the neck musculature. Aggressive treatment can be associated with survival rates of up to 81% for cases due to Cl. perfringens alone. Survival rates for other Clostridial spp. tend to be lower. POTENTIAL RELEVANCE: A combination of high dose i.v. antibiotic therapy and surgical fenestration/debridement is the best approach to cases of clostridial myonecrosis. With rapid diagnosis and therapeutic intervention, horses may have up to an 81% chance of survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12553469     DOI: 10.2746/042516403775467513

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  12 in total

1.  Assessment of the CoaguChek-XS portable prothrombin time point-of-care analyzer for horses.

Authors:  Noa Berlin; Efrat Kelmer; Gilad Segev; Itamar Aroch; Gal Kelmer
Journal:  J Vet Diagn Invest       Date:  2019-03-11       Impact factor: 1.279

Review 2.  Gas gangrene in mammals: a review.

Authors:  Carlos A Oliveira Junior; Rodrigo O S Silva; Francisco C F Lobato; Mauricio A Navarro; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2020-02-21       Impact factor: 1.279

3.  Fatal non-traumatic gas gangrene caused by Clostridium perfringens type A in a Siberian Husky dog.

Authors:  Cleide H Sprohnle-Barrera; Justine S Gibson; Rochelle Price; Rikki M Graham; Amy V Jennison; Madeline R Ricca; Rachel E Allavena
Journal:  J Vet Diagn Invest       Date:  2022-02-18       Impact factor: 1.569

4.  Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses.

Authors:  L Hunyadi; E A Sundman; P H Kass; D C Williams; M Aleman
Journal:  J Vet Intern Med       Date:  2017-01-02       Impact factor: 3.333

Review 5.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

6.  Pathogenicity and virulence of Clostridium perfringens.

Authors:  Iman Mehdizadeh Gohari; Mauricio A Navarro; Jihong Li; Archana Shrestha; Francisco Uzal; Bruce A McClane
Journal:  Virulence       Date:  2021-12       Impact factor: 5.428

7.  Infections with spore-forming bacteria in persons who inject drugs, 2000-2009.

Authors:  Norah E Palmateer; Vivian D Hope; Kirsty Roy; Andrea Marongiu; Joanne M White; Kathie A Grant; Colin N Ramsay; David J Goldberg; Fortune Ncube
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

8.  Acute myonecrosis in horse caused by Clostridium novyi type A.

Authors:  Luana D'avila Farias; Marcos Da Silva Azevedo; Maria Elisa Trost; Flávio Desessards De La Côrte; Luiz Francisco Irigoyen; Agueda Castagna de Vargas
Journal:  Braz J Microbiol       Date:  2014-04-08       Impact factor: 2.476

9.  An unusual necrotic myositis by Clostridium perfringens in a German Shepherd dog: A clinical report, bacteriological and molecular identification.

Authors:  Hamideh Salari Sedigh; Masoud Rajabioun; Jamshid Razmyar; Hossein Kazemi Mehrjerdi
Journal:  Vet Res Forum       Date:  2015-12-15       Impact factor: 1.054

10.  Rhabdomyolysis and Acute Renal Failure Associated with Oxytetracycline Administration in Two Neonatal Foals Affected by Flexural Limb Deformity.

Authors:  Nicola Ellero; Francesca Freccero; Aliai Lanci; Maria Morini; Carolina Castagnetti; Jole Mariella
Journal:  Vet Sci       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.